Table 1 Clinicopathological characteristics of the patients
Characteristics | No. of patients | % | N (total) |
|---|---|---|---|
Sex | 106 | ||
Male | 77 | 73 | |
Female | 29 | 27 | |
Age | |||
Median | 57 | ||
Range | 35–83 | ||
T-stage | 106 | ||
1 | 25 | 24 | |
2 | 31 | 29 | |
3 | 17 | 16 | |
4 | 31 | 29 | |
N-stage | 105 | ||
0 | 18 | 17 | |
1 | 21 | 20 | |
2a | 3 | 3 | |
2b | 30 | 28 | |
2c | 16 | 15 | |
3 | 14 | 13 | |
M-stage | 103 | ||
0 | 95 | 92 | |
1 | 8 | 8 | |
Treatment | 100 | ||
Surgery | 76 | 76 | |
Surgery+RT/RCT | 55 | 55 | |
RT/RCT alone | 24 | 24 | |
Survivin score | 94 | ||
0 | 16 | 17 | |
1 | 9 | 10 | |
2 | 16 | 17 | |
3 | 23 | 25 | |
4 | 30 | 32 | |
Survivin nuclear expression | 94 | ||
+ | 18 | 19 | |
− | 76 | 81 | |
p16 overexpression | 101 | ||
+ | 40 | 40 | |
− | 61 | 60 | |
HPV detection | 102 | ||
+ | 30 | 29 | |
− | 72 | 71 |
